Cargando…

Baseline characteristics associated with survival in patients with hepatocellular carcinoma

BACKGROUND AND AIM: Hepatocellular carcinoma (HCC) is one of the most common and most lethal cancers worldwide. The objective of this study was to investigate the relationship between basal parameters and survival characteristics in patients with HCC. MATERIALS AND METHODS: The records of 1447 HCC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aslanov, Seymur, Gulsen Unal, Nalan, Senkaya, Ali, Celik, Ferit, Murat Buyruk, Abdullah, Uysal, Alper, Akyildiz, Murat, Turan, Ilker, Gunsar, Fulya, Ersoz, Galip, Zeki Karasu, Abdullah, Omer Ozutemiz, Ahmet, Salih Akarca, Ulus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2021
Materias:	Research Article - Features and survival in hepatocellular carcinoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138914/ https://www.ncbi.nlm.nih.gov/pubmed/35782371 http://dx.doi.org/10.14744/hf.2021.2021.0031

Ejemplares similares

Hepatitis E virus IgG seroprevalence in liver transplant patients: A retrospective single-center experience
por: Celik, Ferit, et al.
Publicado: (2021)

Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients
por: Mut Surmeli, Deniz, et al.
Publicado: (2021)

A single-center experience: Liver biopsy results during a year
por: Emre Meral, Cenk, et al.
Publicado: (2022)

Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis
por: Demirciler, Erkut, et al.
Publicado: (2023)

The use of fully covered self-expandable metal stents in the endoscopic treatment of portal cavernoma cholangiopathy
por: Buyruk, Abdullah Murat, et al.
Publicado: (2023)

Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study
por: Oruc, Nevin, et al.
Publicado: (2009)

Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000–20000 IU/ml with ALT 1–2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT
por: Danis, Nilay, et al.
Publicado: (2021)

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation
por: Wan, Ping, et al.
Publicado: (2014)

Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma
por: Huang, Fei, et al.
Publicado: (2022)

Recent Update on Immunotherapy and Its Combination With Interventional Therapies for Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study
por: Liu, Shanshan, et al.
Publicado: (2023)

Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Zhao, Dongxu, et al.
Publicado: (2023)

Artificial intelligence method to predict overall survival of hepatocellular carcinoma
por: Simsek, Cem, et al.
Publicado: (2021)

Laser therapy as a treatment for chronic radiation fibrosis
por: Wilson, Britney, et al.
Publicado: (2022)

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2021)

Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
por: Liu, Ze-Long, et al.
Publicado: (2021)

Dieulafoy lesions: One patient, two different localizations
por: Şenkaya, Ali, et al.
Publicado: (2022)

Association of LCT-13910 C/T Polymorphism and Colorectal Cancer
por: Gençdal, Genco, et al.
Publicado: (2017)

Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment
por: Da Rosa, M.R., et al.
Publicado: (2011)

The Significance of the Presence of Lactic Acid, and of Deficiency or Absence of Free Hydrochloric Acid, in the Gastric Contents as a Means of Diagnosis
Publicado: (1907)

Bronchoscopic Diagnosis of Carcinoma of the Lung
por: Scarff, Gordon
Publicado: (1936)

Primary Carcinoma of the Lung Radiologically Considered
por: Bush, Gilbert B.
Publicado: (1936)

The Treatment of Carcinoma of the Lung
por: Wood, Duncan
Publicado: (1936)

The Pathological Aspect
por: Taylor, Arthur L.
Publicado: (1936)

Clinical Features
por: Perry, C. Bruce
Publicado: (1936)

Nasopharyngeal carcinoma – Improving cure with technology and clinical trials
por: Tsang, Raymond K.
Publicado: (2020)

Real time in-vivo miniature endoscopic surveillance system for imaging of nasopharynx
por: Lim, Chwee Ming, et al.
Publicado: (2020)

Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
por: Ghosh-Laskar, Sarbani, et al.
Publicado: (2020)

Dysphagia after chemo-radiation for nasopharyngeal cancer: A scoping review
por: Fong, Raymond, et al.
Publicado: (2020)

Repeated exposure to fractional CO(2) laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line‐field confocal optical coherence tomography and histology
por: Olesen, Uffe H., et al.
Publicado: (2022)

Survival from cancer of the rectum in England and Wales up to 2001
por: Mitry, E, et al.
Publicado: (2008)

Survival from melanoma of the skin in England and Wales up to 2001
por: Rachet, B, et al.
Publicado: (2008)

Survival from testicular cancer in England and Wales up to 2001
por: Nur, U, et al.
Publicado: (2008)

Survival from cancer of the oesophagus in England and Wales up to 2001
por: Mitry, E, et al.
Publicado: (2008)

Survival from cancer of the lung in England and Wales up to 2001
por: Rachet, B, et al.
Publicado: (2008)

Survival from cancer of the pancreas in England and Wales up to 2001
por: Mitry, E, et al.
Publicado: (2008)

Survival from non-Hodgkin lymphoma in England and Wales up to 2001
por: Rachet, B, et al.
Publicado: (2008)

Survival from multiple myeloma in England and Wales up to 2001
por: Rachet, B, et al.
Publicado: (2008)

Survival from cancer of the stomach in England and Wales up to 2001
por: Mitry, E, et al.
Publicado: (2008)

Survival from cancer of the uterine cervix in England and Wales up to 2001
por: Quinn, M J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_cfjg4tmqelsduhnuu5udkhmqtn